Interestingly, xenografts generated from sorted CD44+CD24neg DT-22 cells consistently contained 2–8% CD44+CD24low cells in all of 18 tumours, raising the possibility of a niche-induced inter-conversion in vivo. This evidence concerns the gene CD44 and neoplasm.